338 related articles for article (PubMed ID: 23666471)
21. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
Mackie PS; Fisher JL; Zhou H; Choong PF
Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
[TBL] [Abstract][Full Text] [Related]
22. Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro.
Roncuzzi L; Marti G; Baiocchi D; Del Coco R; Cocchi S; Gasperi-Campani A
Oncol Rep; 2006 Jan; 15(1):73-7. PubMed ID: 16328036
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.
Yoshitani K; Honoki K; Morishita T; Kido A; Miyauchi Y; Mii Y; Takakura Y
In Vivo; 2003; 17(3):255-8. PubMed ID: 12929576
[TBL] [Abstract][Full Text] [Related]
24. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells.
Zhou R; Zhang Z; Zhao L; Jia C; Xu S; Mai Q; Lu M; Huang M; Wang L; Wang X; Jin D; Bai X
J Orthop Res; 2011 Jun; 29(6):846-52. PubMed ID: 21246613
[TBL] [Abstract][Full Text] [Related]
26. The possible role of insulin-like growth factor-1 in osteosarcoma.
Li YS; Liu Q; He HB; Luo W
Curr Probl Cancer; 2019 Jun; 43(3):228-235. PubMed ID: 30217668
[TBL] [Abstract][Full Text] [Related]
27. The role of STAT3 in autophagy.
You L; Wang Z; Li H; Shou J; Jing Z; Xie J; Sui X; Pan H; Han W
Autophagy; 2015; 11(5):729-39. PubMed ID: 25951043
[TBL] [Abstract][Full Text] [Related]
28. HER-2 involvement in osteosarcoma.
Gill J; Geller D; Gorlick R
Adv Exp Med Biol; 2014; 804():161-77. PubMed ID: 24924174
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
30. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
31. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Toyota H; Kondo S; Kyo S; Mizuguchi J
Anticancer Res; 2006; 26(1A):99-105. PubMed ID: 16475685
[TBL] [Abstract][Full Text] [Related]
32. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
33. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
34. Growth factors, their receptor expression and markers for proliferation of endothelial and neoplastic cells in human osteosarcoma.
Bianchi E; Artico M; Di Cristofano C; Leopizzi M; Taurone S; Pucci M; Gobbi P; Mignini F; Petrozza V; Pindinello I; Conconi MT; Della Rocca C
Int J Immunopathol Pharmacol; 2013; 26(3):621-32. PubMed ID: 24067459
[TBL] [Abstract][Full Text] [Related]
35. Redundancy of autocrine loops in human osteosarcoma cells.
Benini S; Baldini N; Manara MC; Chano T; Serra M; Rizzi S; Lollini PL; Picci P; Scotlandi K
Int J Cancer; 1999 Feb; 80(4):581-8. PubMed ID: 9935160
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in osteosarcoma.
Botter SM; Neri D; Fuchs B
Curr Opin Pharmacol; 2014 Jun; 16():15-23. PubMed ID: 24632219
[TBL] [Abstract][Full Text] [Related]
37. TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.
Guiho R; Biteau K; Heymann D; Redini F
Future Oncol; 2015; 11(3):535-42. PubMed ID: 25675131
[TBL] [Abstract][Full Text] [Related]
38. miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy.
Li X; Wang S; Chen Y; Liu G; Yang X
Tumour Biol; 2014 Jun; 35(6):6021-8. PubMed ID: 24609901
[TBL] [Abstract][Full Text] [Related]
39. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?
Kager L; Diakos C; Bielack S
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1025-8. PubMed ID: 25882838
[TBL] [Abstract][Full Text] [Related]
40. Targeting the centrosome and polo-like kinase 4 in osteosarcoma.
Kelleher FC; Kroes J; Lewin J
Carcinogenesis; 2019 Jun; 40(4):493-499. PubMed ID: 30508038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
